Marc H V Van Regenmortel is currently an Emeritus Research Director at the CNRS (French National Research Center) in the School of Biotechnology of the University of Strasbourg, France. He was for 22 years Director of the Immunochemistry Laboratory at the CNRS Molecular Biology Institute in Strasbourg and previously was a professor at several universities in South Africa and France. He served (1984-1990) as Vice Chairman and Chairman of the Virology Division of the International Union of Microbiological Societies (IUMS) and was Secretary General of IUMS from 1990 to 1999. He was also for six years (1996-2002) President of the International Committee on Taxonomy of Viruses. He supervised the research work of 30 PhD students and has published 395 research and review papers as well as 17 books in the fields of Virology and Immunochemistry. In 2009 he co-edited with Brian Mahy of the CDC in Atlanta, the third edition of the Encyclopedia of Virology in 5 volumes published by Elsevier.
He is currently Editor-in-Chief of ARCHIVES OF VIROLOGY and JOURNAL OF MOLECULAR RECOGNITION, an Executive Editor of ANALYTICAL BIOCHEMISTRY, an Associate Editor of ADVANCES IN VIRUS RESEARCH, FRONTIERS IN IMMUNOTHERAPIES AND VACCINES, JOURNAL OF IMMUNOLOGICAL METHODS, ISRN IMMUNOLOGY, BIONOMINA and EXPERT REVIEWS OF PROTEOMICS

General virology, Immunochemistry of viruses, viral diagnostics, synthetic peptide vaccines, HIV vaccines, SPR biosensors, viral taxonomy, philosophy of science

Dr Vincent Marconi received his MD   in the Johns Hopkins University School of Medicine during the period  of 1996 to 2000. Thereafter he received training in Internal Medicine and Infectious Diseases at the Brigham and Women’s Hospital and the Massachusetts General Hospital, Harvard Medical School.  Currently,  he is an Associate Professor in the School of Medicine and jointly in the School of Public Health at Emory University. He is currently the Associate Medical Director of the Infectious Disease Program of Grady Memorial Hospital. He is serving as a reviewer for several reputed journals like Clinical Infectious Diseases, Journal of AIDS and Journal of Infectious Diseases. He has co-authored over 40 research articles. He is a member of the IDSA and the HIVMA. He has been honored as the 2008 USAF Chapter American College of Physicians Major General Archie Hoffman Award. 
 

The main focus of Dr. Marconi&middot′s research is to identify the underlying biological and socioeconomic conditions which lead to differences in HIV treatment response for domestic and international populations.  Results from these studies inform the design of interventional trials which attempt to mitigate these conditions in an experimental setting.  The goal of these trials is to improve patient care and characterize the pathogenesis of HIV treatment response.

 

Ph.D. in Health Psychology (Athens, Panteion University), M.Sc. Social exclusion and minorities (Panteion University), Social Administration - Management of Health Services (Athens, National School of Public Administration), B.Sc. (Psychology) (Panteion University), B.Sc. (Social Work) (Technological Educational Institute of Athens)

Psychosocial processes, outcomes and quality of life in chronic illness with particular emphasis on chronic kidney disease, dialysis and renal transplantation
Self management interventions for patients with chronic illness
Palliative care in severe chronic disease
 

Fatah Kashanchi, Professor; PhD., Kansas, 1991. Dr. Kashanchi obtained his PhD. from the University of Kansas with Dr. Charles Wood who was instrumental in the development of the Abbot HIV-1 gp120 ELISA assay in 1986 and was trained under supervision of Dr. Susumu Tonegawa (Nobel Laurate for Medicine, 1987) at MIT. Dr. Kashanchi further trained in Dr. John Brady’s lab at NIH/NCI from 1991-1998 and published more than 30 papers during his postdoc and senior investigator tenure.  His research interests include both Genomics and Proteomics of HIV-1 and HTLV-1 infected cells. Research in Kashanchi lab has been funded by various internal and external sources including GW-REF, Selective Excellence, Keck, Snyder, Sinsheimer, Cyclacel, DOD, and more than 6 NIH grants, where he is the Principal investigator.  In total, he has obtained $8.9 M independent funding since his departure from NIH in 1998. He has 92 peer-reviewed publications in scientific journals, 7 book chapters, is an NIH study section member (5 independent study sections), as well as reviewer for 12 different journals and an editor for Retrovirology (2005) and JBC (Dec 2006). Dr. Kashanchi has trained and supported 14 postdocs, 9 Ph.D. students, 19 MS, and 5 Research Assistant Professors since 1999. Finally, he is the co-Director of the Keck Institute of Proteomics and director of the MS program in Genomics, Proteomics and Bioinformatics at the George Washington University Medical School

research interests include both Genomics and Proteomics of HIV-1 and HTLV-1 infected cells.

Mary G van den Berg-Wolf MD, FACP, AAHIVS is a Professor of Medicine at Temple University School of Medicine in Philadelphia, PA.  She is also deputy director of the Temple’s HIV Primary Care Practices there.  She completed her MD at Georgetown University in 1979 and her BS in Chemistry at the University of Michigan in 1975.  She completed a residency in Internal Medicine at both the Temple University as well as at the Free University of Amsterdam in the Netherlands in 1985.  She has been an Internist and has been treating HIV-infected patients in the Netherlands until 1994 and she has been at Temple University since 1995 practicing primary care HIV medicine and doing research.  She has received the distinction of membership into the Philadelphia College of Physicians and she is a Fellow in the American College of Physicians.  She is a member of the American Academy of HIV Medicine and serves as the Pennsylvania State chapter chairperson for the American Academy of HIV Medicine.  The AAHIVS after her name indicates that she is certified by that body as an HIV Specialist.  She has served as a reviewer of 3 journals and has published more than 20 articles in peer- reviewed periodicals and e-journals.
 

Reducing cardiovascular risk in HIV- infected people
Novel treatment regimens in HIV therapy
Depression and HIV
Women and HIV
Teaching the ambulatory care of HIV-infected patients
 

Rachel L. Chin, MD
Professor
Clinical Emergency Medicine
San Francisco  School of Medicine
San Francisco, CA 94110, USA

Professor,
Growth and Development DepartmentUNMC College of Dentistry

Basic Science and Clinical Pediatric Dentistry Research, Dental Materials, Education

Kenneth C. Williams, PhD
Professor
Biology Department
Boston College, Chestnut Hill
Massachusetts, USA

 

Central nervous system macrophages, neuroAIDS, AIDS pathogenesis, monocyte/macrophage biology.

Bindong Liu
Associate Professor
Department of Microbiology and Immunology
Meharry Medical College School of Medicine
Nashville, USA

molecular biology of HIV-1 with the emphasis on the interaction between HIV-1 and host, and the interaction of HIV-1 with other microbes. 

Maria Jose Míguez is a medical Doctor with a PhD in immunologist. She has completed her Post-Doctoral fellowship in Immunology; Fellow in Immunology in 1993 and Post-Doctoral Scholar in AIDS, TB, Fogarty Fellow in1994 at the University of Miami School of Medicine. She is Associate Professor at the School of Public Health and the Department of Immunology in the School of Medicine.  She received the Madison’s Who’s Who in America, 2010, the National Leadership Award. Business Advisory Council. Washington, 2006 and Women of the Year 2005 award for her contribution to Immunology. She is serving as an editorial board member of reputed journals and reviewer of 7 journals. She has authored over 70 scientific publications and she is recognized as an international speaker.

 

IgE
Infectious diseases, particularly HIV/TB
Health and Immune consequences of alcohol and or tobacco
Platelets
Risk Behaviors
 

Jennifer Kim Plybon Penberthy, is an Associate Professor of Psychiatry in Department of Psychiatry & Neurobehavioral Sciences at University of Virginia School of Medicine, Charlottesville, VA
Director of Training and Chief, Center for Addiction Research and Education, Division of Neurobiology
Masters degree in Experimental Psychology from Wake Forest University, Winston-Salem, NC in 1992
PhD in Clinical Psychology from Virginia Commonwealth University, Richmond VA in 1998
Fellowship in Medical Psychology from University of Virginia SOM, Charlottesville, VA 2000
Winner of the Funding Excellence in Science and Technology Award at UVA 2002
Elected to the Academy of Distinguished Educators at UVA SOM 2006
Serving as an editorial board member of reputed journals and reviewer in multiple journals
 

Development of effective behavioral treatments that are individualized based upon environmental and behavioral characteristics
Assessment of mechanisms of action of behavioral treatments for psychiatric disorders and addictions
 

Nancy F. Crum-Cianflone MD MPH is an Infectious Diseases Staff at the Naval Medical Center San Diego, California and a Research Physician with the Infectious Diseases Clinical Research Program.  She also is an Associate Professor of Preventive Medicine and Biometrics at the Uniformed Services University of the Health Sciences, Bethesda, Maryland; Voluntary Associate Clinical Professor at the University of San Diego, California; and Adjunct Professor in Public Health and Epidemiology at San Diego State University.
She has a Doctorate of Medicine Degree from the University of Chicago, a Masters Degree in Public Health from San Diego State University, and a Bachelor’s of Art Degree from Wittenberg University.
Dr. Crum-Cianflone serves on the Publications Committee for the Clinical Infectious Disease Journal and the Journal of Infectious Diseases.  She is also an editorial Board Member for both Infectious Disease in Clinical Practice and AIDS Patient Care and STDs.  She also reviews articles for over 20 journals.

She has published over 100 journal articles in peer-reviewed journals, and continues to be an avid researcher in the field of Infectious Diseases and HIV.

 

-Comorbidities among HIV-infected persons including cancers, liver disease, and cardiovascular disease
-Co-infections in HIV-infected persons including HSV, HHV8
-Vaccine research among immunosuppressed persons
-Endemic mycoses - coccidioidomycosis

 

Prof Bianca R. Mothé received her PhD at the University of Wisconsin-Madison during the period of 1998-2002. Currently, she is working as an Associate Professor at the California State University- San Marcos. She has successfully completed her Administrative responsibilities as the Biotechnology Program Coordinator. She has authored 27 research articles. She has been honored as a Fulbright Scholar in 2009-2010 in the Brazil program.

 

My research lies in the interface of the host-pathogen relationship. I am interested in how pathogens evade the host immune response. I have focused on the host immune response, including MHC identification and charactization as well as epitope identification. The goal is to define the role of epitope responses after infection with different pathogens, including Human Immunodeficiency Virus, Simian Immunodeficiency Virus, Tuberculosis, Dengue Virus, Lymphocytic choriomeningitis Virus and Influenza in varying animal models (such as mouse, ferret and non-human primate) and human systems. Insight into these areas can be used for diagnostic kit and vaccine development. 

Igho Ofotokun, MD
Associate Professor
Division of Infectious Diseases
Emory University School of Medicine
Atlanta, GA 30303, USA

Paula Frew is an Assistant Professor of Medicine, Division of Infectious Diseases, Emory University - Atlanta, Georgia . And Assistant Professor of Behavioral Sciences and Health Education, Emory University Rollins School of Public Health – Atlanta, Georgia . She is also Director of Communications and Community Research at the Hope Clinic of the Emory Vaccine Center. She has received a PhD in Health Promotion and Behavior from the University of Georgia, Athens, GA, 2005-2007. She completed a MPH in Prevention Science from Emory University Rollins School of Public Health, Atlanta, GA (2001) and an MA degree from San Diego State University, San Diego, California (1997). She has completed her B.A in Sociology and Theatre from the University of California at San Diego (UCSD), La Jolla, CA (1990). She has received numerous awards and honors including  the “Gerald A. Ludd Lifetime Award for Excellence in Support of HIV/AIDS and Community Service” in 2009 from National AIDS Education and Services for Minorities. She is an active reviewer of 14 journals including JAIDS, AIDS & Behavior, Prevention Science and others.

Community Participation in Clinical Research
Recruitment and Retention in HIV Prevention Research
HIV Community Prevention Strategies
HIV Prevention Technology Acceptability Studies
Health Communication Approaches for Clinical Research.

 

Dr. Han-Zhu Qian has received his PhD in University of Alabama at Birmingham during the period of 2000 to 2005. Currently, he is working as an Assistant Professor in Vanderbilt University. He has successfully completed his Administrative responsibilities as the Chair of Epidemiology Subcommittee for NHLBI Global Health Initiatives of Combating Non-Communicable Chronic Cardiovascular and Pulmonary diseases (CVPD) in Developing Countries. He is serving as a frequent peer reviewer of several reputed journals like Tropical Medicine and International Health and Journal of Substance Abuse Treatment. He has authored over 60 research articles/books. He is a member of International AIDS Society and International Epidemiological Association. He has honored as a Newman Society member.

Dr. Qian’s research has focused on epidemiology and prevention intervention of infectious diseases, including HIV, sexually transmitted infections, hepatitis C and B, and tuberculosis among vulnerable populations. Specific research fields include substance abuse (both injection and non-injection) and HIV risk and disease progression, male circumcision and HIV/HPV risks among men who have sex with men (MSM), and HIV testing and linkage to care among MSM, drug users, and prisoners.

John K. Williams, M.D., is an Assistant Professor in the Department of Psychiatry & Biobehavioral Sciences at UCLA. He completed his M.D. degree at the State University of NY at Syracuse, his Psychiatry residency at the University of Hawaii and an NIMH sponsored two-year HIV/AIDS research postdoctoral fellowship at UCLA. He has expertise in HIV risk reduction in diverse populations especially among minority men who have sex with men (MSM), the use of the Internet for research purposes, and mental health disparities and cross-cultural Psychiatry (i.e., cultural predictors of depression and anxiety among ethnic minority youths).  Dr. Williams was funded as a Minority AIDS Research Initiative (MARI) Investigator by the CDC.  He is currently funded to develop an HIV prevention intervention for non-gay identifying African American men who have sex with men and women (MSMW).  He is also funded through NIMH to develop an HIV risk reduction intervention for HIV-positive African American MSMW who have a history of childhood sexual abuse and to examine biomarkers of stress.  Both interventions examine the stigma of being labeled “gay” and attempts to alter sexual risk behaviors among these men as they struggle with their sexual identity.  Dr. Williams is also the Training Director for a Fogarty International Trauma Training Grant with the University of Limpopo in South Africa entitled, The UCLA-South African Research in Trauma Training Program (Phodiso) and Co-Director of Training & Education for the Prevention & Clinical Research Core of the UCLA AIDS Institute.  He is also the Training Director and Community Liaison for the NIH funded Center for Culture, Trauma and Mental Health Disparities.

HIV prevention intervention

Jason F. Okulicz  is the Director of the HIV Evaluation Unit at Wilford Hall and Brooke Army Medical Centers in San Antonio, TX. His academic positions include Assistant Professor of Medicine, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, Clinical Assistant Professor in Medicine, University of Texas Health Science Center at San Antonio, and Adjunct Clinical Instructor, Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX. He completed his BS in Pharmacy at the Rutgers University College of Pharmacy in 1998. He then received his MD degree at the University of Medicine and Dentistry of New Jersey – New Jersey Medical School in 2002. He then completed residency in Internal Medicine and Fellowship in Infectious Diseases at Wilford Hall and Brooke Army Medical Centers. He is a reviewer for Clinical Infectious Diseases, Pharmacotherapy, Journal of Clinical Microbiology, and Military Medicine.

Antiretroviral therapy treatment response and clinical outcomes
Pharmacology of antiretroviral agents
HIV pathogenesis
HIV controllers (elite and viremic controllers) and long-term nonprogressors (LTNP)
 

Sandra Springer, MD is an Assistant Professor of Medicine in the Department of Internal Medicine, section of Infectious Diseases at the Yale School of Medicine. She is Board-Certified in Internal Medicine, Infectious Diseases and Addiction Medicine. Dr. Springer has significant research experience with adherence interventions for HIV-infected drug and alcohol dependent persons. She was a recipient of a NIDA-funded K23 mentored career development award, during which she evaluated the use of medication assisted treatment (MAT) to prevent relapse to opioid use as a conduit to care among HIV-infected opioid dependent released prisoners. She developed the first protocol to use buprenorphine as relapse prevention for opioid dependent HIV+ prisoners on day of release and has published these findings that serve as proof of concept that MAT can be effective in maintaining HIV+ released prisoners HIV clinical outcomes. She also has expertise in supervising RCTs by serving as medical director and co-investigator for multiple RCTs including DAART adherence interventions for IDUs and HIV+ released prisoners. She also has considerable clinical and research experience with the use of extended-release naltrexone and has been awarded an R01 from NIAAA as Principal Investigator to evaluate its use to prevent relapse to alcohol use among HIV infected alcohol dependent prisoners transitioning to the community, and from NIDA as PI as part of the Seek Test Treat and Retain initiative to evaluate its use to prevent relapse to opioid use among opioid dependent released criminal justice populations as a means to maintain HIV treatment outcomes. She is also a co-investigator on an R01 from NIDA with Dr. Altice evaluating the use of buprenorphine as linkage to HIV testing and conduit to care for opioid dependent persons in Washington D.C. She has recently received a K02 independent scientist award from NIDA as well. Dr. Springer has expertise in the development and implementation of medication-assisted-therapy interventions involving HIV+, drug and alcohol dependent persons involved in the criminal justice setting.
 

Improving adherence to antiretrovirals and drug treatment for HIV infected opiate and alcohol dependent men and women.
 

R. Douglas Bruce, MD
Assistant Professor
Yale University School of Public Health
New Haven, CT, USA

Neha Nanda, MD
Assistant Professor of Medicine
Section of Infectious Diseases
Yale School of Medicine
USA

Dr. Wen Guo is an assistant professor of Endocrinology Section at Boston University School of Medicine. She has received a PhD in Physical Chemistry from the University of Oklahoma. She received a postdoctoral training in Biophysics at Boston University and moved to the field of Metabolism, Obesity, and HIV-related premature atherosclerosis and aging. She has over 50 publications and has served as a reviewer for Diabetes, Obesity, Journal of Lipid Research, and several other journals. She has served at special study sections for project programs of National Institute of Aging and participated in grant review for National Research Foundation of Singapore. Research in Dr. Guo’s laboratory is currently funded by NIDDK and NIA.

Body composition, insulin resistance, and atherosclerosis. Antiretrovial drugs and premature atherosclerosis. Antiretrovial drugs, muscle insulin resistance, and premature aging. Aging and joint dysfunction

Dr. Mirko Paiardini received his Ph.D. from the University of Urbino, Italy, in 2003. Between 2006 and 2010 Dr. Paiardini was a Research Associate at the University of Pennsylvania. Currently, he is an Assistant Professor at Emory University in the Yerkes National Primate Research Center. He has authored 46 original, peer-reviewed scientific publications, and he has been invited to present his research in several prestigious international meetings. He is a reviewer for several reputed journals, including PLoS ONE, Journal of Virology, Journal of Infectious Diseases, Vaccine, FASEB Journal.
 

Pathogenesis of the AIDS-associated immunodeficiency. In particular, he is interested in defining the immunological features allowing SIV-infected natural hosts, such as sooty mangabeys, to avoid progression to AIDS despite chronic high levels of SIV replication. To this aim, Dr. Paiardini performs comparative studies in SIV-infected sooty mangabeys (natural host) and rhesus macaques (non-natural host), as well as HIV-infected humans. Dr. Paiardini’s recent research suggests that preservation of Th17 cell homeostasis, particularly at the mucosal sites, and the ability to reduce the susceptibility of central memory CD4+ T cells to virus infection are critical for the ability of sooty mangabeys to remain AIDS-free.
 

Naasha J. Talati, MD
Assistant Professor & Director
Division of Infectious Diseases
Emory University School of Medicine
Atlanta, GA 30313, USA

Saad B. Omer, PhD
Assistant Professor
Global Health, Epidemiology, and Pediatrics
Emory University
USA

Dr. David Pantalone serves as Assistant Professor of Psychology and Director of the Laboratory on Stress and Health at Suffolk University, and Behavioral Scientist at The Fenway Institute of Fenway Community Health, both in Boston, Massachusetts, USA. He completed his undergraduate degree in public policy at Brown University, and his doctorate in clinical psychology at the University of Washington, Seattle. His clinical psychology internship was at the Seattle VA Medical Center and his postdoctoral research training in health psychology was at the Center for HIV/AIDS Educational Studies and Training of Hunter College/City University of New York. He has worked on NIH-funded HIV prevention and treatment research for more than 10 years, and has authored peer reviewed publications in top journals (JCCP, JAIDS, STI). He has held leadership roles in professional organizations, including the American Psychological Association and the Association for Behavioral and Cognitive Therapies.
 

Dr. Pantalone has several interrelated line of research. His primary interests concern HIV prevention and treatment, including work on interventions aimed at improving psychosocial factors that drive risk behaviors and non-adherence. His work also focuses on other risky behaviors, such as alcohol and substance use, as well as interpersonal violence and its effects on physical health and functioning.
 

Shi Lizheng, PhD
Assistant Professor of Health System Management
Internal Medicine
Psychiatry and Neurology
Tulane University
New Orleans, Louisiana, USA

Health technology assessment (cost of illness, cost-benefit, cost-effectiveness, cost utility) and health care quality, access, and evaluation. He is also interested in pharmacoepidemilogy with a focus on safety issues in medication treatment and medical informatics to improve quality and safety of patient care.

Minh Ly Nguyen, MD
Assistant Professor
Division of Infectious Diseases
Emory University School of Medicine, USA

Nadine Rouphael, MD
Assistant Professor
Division of Infectious Diseases
Emory University School of Medicine
USA

Dr. Prema Menezes PhD, PA-C is an Epidemiologist and Clinical Scientist with a broad background that includes 12 years of HIV clinical care and direct involvement in the design, conduct and implementation of clinical trials and translational and laboratory based research. She is  Co-Director of the UNC Center for AIDS Research – Clinical Core; sub-investigator in the AIDS Malignancy Consortium at UNC; and an adjunct professor at Duke University.; conduct of clinical trials - ethics, good clinical practice, CONSORT.  She teaches graduate students at UNC and Duke University and provides mentorship to masters, doctoral and post doctoral students. She is the course coordinator and co-Instructor for the clinical trials course for the graduate program at UNC. She has collaborated in several successful NIH funded grant applications.

HIV Clinical Trials - design, analysis, interpretation and reporting; trial effect in clinical trials and how it influences Outcomes; barriers and motivators to clinical trial participation.
 

Dr. Castillo was born in Peru and obtained his Medical Degree in Mexico City. He completed his Internal Medicine Residency in Framingham, MA and was a Fellow in Hematology/Oncology at Brown University. He currently is an Assistant Professor for the Warren Alpert Medical School of Brown University. Since 2009, Dr. Castillo is a Principal Investigator for the AIDS Malignancy Consortium (AMC), a National Cancer Institute (NCI)-supported clinical trials group founded in 1995 to support innovative trials for AIDS-related cancers. Additionally, he is also a Principal Investigator for the Brown University Oncology Group (BRUOG) and the Center for AIDS Research (CFAR) at Brown University, and a Member of the AIDS and Cancer Specimen Resource (ACSR) Research Evaluation and Decision Panel.

Epidemiology, prognostic factors, diagnosis and therapy of lymphoma, leukemia, myeloma and HIV/AIDS-related malignancies. He is also interested on outcomes research using meta-analytical methodologies

Dr. Richard Jurevic is an Assistant Professor in the Dept. of Biological Sciences. He received his undergraduate and Dental degrees from the Ohio State University. At the University of Washington, he completed specialty training in Oral Medicine and Radiology and a fellowship in Special Care Dentistry, and a PhD in Oral Biology.Dr. Jurevic is currently funded through the NIH/NIDCRinvestigating oral mucosal immunity and oral manifestations of HIV/AIDS, and the effect of genetic variation of innate immune genes has on the  oral cavity in HIV infected populations. He is also investigating the complex bacterial and fungal relationships (MycoandMicrobiome) and metabolomics profiles of patients with oral mucositis as sequelae of cytotoxic chemotherapy treatments.

Genetic basis of oral disease and the association of single nucleotide polymorphisms (SNPs) and copy number polymorphisms (CNPs) in the epithelial expressed antimicrobial peptide family known as Defensins.

Jay B. Varkey, MD
Assistant Professor of Medicine
Director Antimicrobial Assistance Program
Division of Infectious Diseases
Emory University Hospital
USA

Berhanu Tameru, PhD
Bioinformatics & Risk Analysis (CCEBRA)
Tuskegee University
Tuskegee, AL 36088, USA

Dr. Thomas Kerr is Co-Director of the Urban Health Research Initiative at the British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), an Associate Professor in the Department of Medicine, Division of AIDS at the University of British Columbia, as well as a Michael Smith Foundation for Health Research Scholar.
Dr. Kerr is a principal investigator of several large cohort studies involving people who inject drugs and individuals living with HIV/AIDS and a key focus of Dr. Kerr’s work has been the scientific evaluation of Insite, North America’s first safer injecting facility. Dr. Kerr has published over 270 scientific papers in international peer-reviewed journals and in 2010, Dr. Kerr was the co-recipient of the inaugural Population and Public Health Research Milestones Initiative Award for his outstanding contribution to developing Canadas research base for harm reduction and health equity approaches to HIV prevention and control.
 

HIV/AIDS, addiction, injection drug use, harm reduction, drug policy

Dr Evan Wood received his PhD  in Clinical Epidemiology at the University  of British Columbia during the period  of 2003. He received his MD from the University of Calgary in 2007. Currently, he is a Clinical Associate Professor in at the University of British Columbia. He also is the Co-Director of the British Columbia Centre for Excellence in HIV/AIDS - Urban Health Research Initiative. He serves as an editorial member of several reputed journals like Addiction Research & Therapy and International Journal of Drug Policy. He has authored over 300 research articles. He is a Division Member of the  Division of AIDS, University of British Columbia. In 2010, Dr. Wood was awarded the International Junior Doctor of the Year by the British Medical Journal (BMJ).

Injection drug use, HIV/AIDS, Population health, Antiretroviral therapy, Epidemiology, Addiction, Urban health

Dr.Kaio Kitazato has received his PhD in Hokkaido University during the period of 1989 to 1991. Currently, he is working as Associate Professor in Nagasaki University. He has authored tens of research articles/books. He is a member of the Japanese society for virology, the Pharmaceutical Society of Japan, Japanese association for antiviral therapy, and the molecular Biology Society of Japan.

Antiviral research Gene therapy Cancer therapy

IvanoMezzaroma was born in Rome, Italy, in 1957. He received the Medicine and Surgery degree (summa cum laude) in 1983 from Sapienza – University of Rome, Italy, and the Allergy, Immunology and Infectious Diseases degrees (summa cum laude) from the same University, in 1988 and 1994, respectively. Since 1990, I. Mezzaroma is with the Department of Clinical Medicine of Sapienza – University of Rome. Presently, he is Assistant Professor at Dpt. of Clinical. He is mainly interested in primary and acquired immune-deficiencies and in treatment of HIV-1 disease. He teaches Internal Medicine, Clinical Immunology and Infectious Diseases at the I School of Medicine (Sapienza – University of Rome). He was Principal investigator/Co-Investigator in several clinical research trials of antiretroviral drugs, vaccines and immunomodulating drugs. He received research fundings by the Italian Institute of Health (ISS) and Italian Ministry of University and Scientific Research (MIUR).

Primary and acquired immune-deficiencies
Treatment of HIV-1 disease

Ellen N Kersh is the Leader of the Immunology Activity within the Preclinical Evaluations Team, Laboratory Branch, Division of HIV/AIDS Prevention at CDC, Atlanta.
Research Associate, Emory University Vaccine Center, 2003 - 2006
Postdoctoral Fellowship award from the Damon-Runyon Walter-Winchell Foundation for work with Dr. Rafi Ahmed, Emory University Vaccine Center, 2000 - 2003
PhD in Biology and Biomedical Sciences, Immunology Program, Washington University in St. Louis, MO, 1994 - 1999
She received a Diploma in Biochemistry (equivalent to combined BS and MS degrees) from the Free University of Berlin, Germany; 1989 – 1994  
 

Macaque Models for HIV Prevention Research
Mucosal Immunity during HIV infection
Resistance factors for HIV infection
Immune Responses to HIV during Prevention Efforts (Pre-exposure Prophylaxis and Vaccines)
Relationship of reproductive issues in women and susceptibility to HIV infection
 

David P. Wilson is Head of Surveillance and Evaluation at the National Centre in HIV Epidemiology and Clinical Research. Associate Professor, Faculty of Medicine, University of New South Wales. He has a PhD in Infectious Disease Modelling, Queensland University of Technology (2003). He has served as an Editorial Board member of numerous journals in infectious diseases.

Understanding HIV transmission risk
Disease surveillance
Epidemic projections
Evaluation of public health programs and interventions

Dr. Di Wu is a Senior Research Associate in Clinical Pharmacology & Therapeutics at Children’s Hospital of Philadelphia (CHOP) and Guest Professor at Central South University.  She serves as Clinical Investigator at Kinetic Modeling and Simulation core of University of Pennsylvania (UPenn)/CHOP Clinical and Translation Science Award supported by US NIH. She received her B.S. in Pharmacy (1992) and M.S. in Biopharmaceutics & Pharmaceutical Analysis from China Pharmaceutical University (1995) and Ph.D. in Pharmacognosy in Michigan State University (2001).  She completed her postdoctoral fellowship in Clinical and Preclinical Pharmacology at Ohio State University (2005).  She published nearly 50 publications and conference abstracts, and serves as a reviewer for five journals (e.g. Journal of Clinical Pharmacology), editorial board member of Journal of AIDS and Clinical Research and Associate Editor of Pharmaceutica Analytica Acta. She was elected to Fellow of Clinical Pharmacology by American College of Clinical Pharmacology in 2009.

Translational medical research
Clinical trial design, operation, data analysis, and report
Pediatric pharmacotherapy
Disease mechanisms
Natural products chemistry (Pharmacognosy)
Individualized therapy
Pharmacometrics
Systems biology
Quantitative and clinical pharmacology
Therapeutic drug monitoring
Regulatory affairs
Therapeutic and drug development & discovery fields
Cardiovascular diseases
HIV infection
Neonatal abstinence syndrome
Central nervous system diseases
Fungal infection and prophylactics in young infants
Osteoporosis
Cancer cachexia
Leishmaniasis and African trypanosomiasis.

Director of Pharmaceutical PolicyBoston University  School of Medicine

HIV/AIDS research

Mark J. Atkinson is a Director of Health Economic and Outcomes Research and a Partner with PRO-Spectus Inc., San Diego, California; he also volunteers his time as a Clinical Associate Professor, Department of Family and Preventive Current Medicine, University of San Diego, San Diego, California, U.S.A. He has received a PhD in Philosophy from the Department of Educational Psychology, University of Calgary, Calgary, Alberta, Canada in, 1993. He completed a B.A (Honors) in Biology at the State University of New York University, White Plains, NY (1983). He currently serves as an editorial board member of two reputed journals, has 59 peer-reviewed publications (21 first authored), and serves as a reviewer for 12 journals.

Scientific advancement of patient-reported outcome (PRO) measurement (e.g., quality of life, treatment satisfaction, symptom impact)
Cognitive theory and patients· health-related decision making
Community-based behavioral and health interventions 
Psychosocial interventions and translational medicine
Structural modeling of disease and treatment impact and other health outcomes.
Advances in innovative qualitative and quantitative research methodologies.

Dr. Soliman is the Director of the Epidemiological Cardiology Research Center (EPICARE), Wake Forest University School of Medicine, Winston-Salem, NC, USA which is the electrocardiogram (ECG) core lab for several NIH-funded studies. He is currently the Principal Investigator of the ECG reading center for a number of population studies and clinical trials including the Strategies for Management of AntiRetroviral Therapy (SMART),
Strategic Timing of Antiretroviral Treatment (START), The Multi-Ethnic Study of Atherosclerosis (MESA), The Hispanic Community Health Study (HCHS) , Jackson Heart Study (JHS), Systolic Blood Pressure Intervention Trial (SPRINT), The Atherosclerosis Risk in Communities Study, the Chronic Renal Insufficiency Cohort study(CRIC), The Action to Control Cardiovascular Disease Risk in Diabetes Follow-on study (ACCORDION), Epidemiology of Diabetes Intervention & Complications Study (EDIC), and many others.

Population electrocardiography
Cardiovascular epidemiology
Global health

Marcela Arrivillaga Quintero is an Associate Professor of the Department of Social Sciences, Pontificia Universidad Javeriana,Cali. Colombia. Director “Health and Quality of Life” Research Group, Pontificia Universidad Javeriana Cali. Colombia. Adjunct Associate Professor. Behavioral Sciences & Health Promotion Division, School of Public Health, University of Texas. Editor in-chief “Pensamiento Psicológico” Journal. She is a Psychologist, with a Masters degree in Education from Pontificia Universidad Javeriana, Cali, Colombia; WHO/PAHO Fellow at the University of Texas; and a Doctorate in Public Health from the “Universidad Nacional de Colombia”. Dr. Arrivillaga is the President of the Latin American Health Psychology Association (ALAPSA), and a founding member of the Social Determinants of Health Commission for Andean Countries.

HIV/AIDS Treatment Adherence
Psychosocial factors related to HIV/AIDS among women.
Social Determinants of Health and HIV/AIDS
Socio-economic status and HIV/AIDS Treatment Adherence
Quality of health care services and HIV/AIDS
Health policies and HIV/AIDS
Access to Antiretroviral Therapy  
Stigma among women living with HIV/AIDS.

Professor Karl Peltzer is Research Director, in the research programme HIV/AIDS, STI and TB (HAST), Human Sciences Research Council, South Africa, an extraordinary Professor in Psychology at Free State University, South Africa, and a Visiting Professor in Psychology at University of Klagenfurt, Austria. He was previously Professor of Psychology and Director of the Health Behaviour Research Unit at the University of Limpopo.
His education is a Dr Habil in Health Psychology from University of Klagenfurt, PhD in Social Health Psychology from University of Hannover and MA in Clinical Psychology from University of Bremen.
He is a prevention researcher and evaluator with over 20 years of experience in the study of health promotion, risk behaviour and disease prevention, and socio-behavioural interventions. Dr Peltzer has published extensively on health behaviour and health interventions (16 books, 350 articles, and 50 book chapers). He has worked extensively on public health subject areas of alcohol, tobacco, cancer, tuberculosis and HIV control; nutrition, physical activity, hypertension, mental health, injury and violence prevention and health promotion.

 Psychology applied to health, health promotion, chronic diseases of life style, substance use, communicable diseases including HIV, injuries, cultural health practices, programme evaluation in low and middle income countries including Africa.

CAPT Peter H. Kilmarx, MD, FACP, FIDSA, is Chief of the Epidemiology Branch of the Division of HIV/AIDS Prevention at the Centers for Disease Control and Prevention (CDC). Dr. Kilmarx graduated from Dartmouth College in 1983 and served in the Peace Corps in Zaire (DRC) as a fisheries volunteer.  He earned his MD degree in the Dartmouth-Brown combined program in medicine, graduating in 1990. After completing internship and residency in internal medicine and a fellowship in infectious diseases at Johns Hopkins in 1994, Dr. Kilmarx joined the CDC Epidemic Intelligence Service in Atlanta. He directed CDC&middot′s northern Thailand HIV/STD prevention field station 1996-2002 and directed CDC&middot′s Botswana office, 2002-05. A Captain in the U.S. Public Health Service and an adjunct professor at Emory University, he is the author or coauthor of more than 100 articles and chapters. He travels every year to treat AIDS patients along the Thai-Lao-Burmese border.

HIV epidemiology HIV prevention HIV program implementation research HIV pre-exposure prophylaxis (PrEP) Microbicides Prevention of mother-to-child HIV transmission Clinical epidemiology Prevention with people living with HIV

Advanced Biomedical Computing Center SAIC Frederick, Inc National Cancer Institute at Frederick Frederick, MD, USA

HIV/AIDS research

Yunda Huang is the Director of Analytics at the Statistics Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Senior Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center. She received a PhD in Biostatistics from the University of California, Los Angeles 1999-2004. She completed her B.S in Statistics from Renmin University of China, Beijing, China 1993-1997. She received Phi Beta Kappa (2002-2003) from UCLA, Raymond D. Goodman Award (2002), School of Public Health, UCLA and Young Investigator Award (2000), Transplant 2000.

Yunda Huang is the Director of Analytics at the Statistics Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Senior Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center. She received a PhD in Biostatistics from the University of California, Los Angeles 1999-2004. She completed her B.S in Statistics from Renmin University of China, Beijing, China 1993-1997. She received Phi Beta Kappa (2002-2003) from UCLA, Raymond D. Goodman Award (2002), School of Public Health, UCLA and Young Investigator Award (2000), Transplant 2000.

Nebraska Center for Virology
University of Nebraska
Morrison Center, 4240
Fair StLincolnNE USA
Tel. 1 402 805 7805
 

HIV/AIDS research

Geoffrey Alan Preidis
Baylor College of Medicine
Health Empowering Humanity
Houston, Texas 77030, USA

HIV/AIDS research

Nuria Garatachea  PhD, is Lecturer of Faculty of Health and Sport, University of Zaragoza, Huesca, Spain. Researcher of Institute of Biomedicine, University of León, León, Spain. Invited researcher of St. John&middot′s Cardiovascular Research Center, Harbor-University of California Los Angeles, USA. She has received a PhD in Philosophy (Physical Activity and Sport Sciences) from the University of León, León, Spain, 2002. He received “Extraordinary Doctorate Award” from University of León, 2004. She is serving as an editorial board member of reputed journals and reviewer of 5 journals.

Physical activity measurement
Exercise physiology
Physical activity and health Training exercise

Department of Epidemiology & Public Health
Yale University School of Medicine.

HIV/AIDS research

Ontreal Chest Institute
3650 rue Saint-Urbain, Canada

The University of New South Wales
Sydney, Australia

Division of Gastroenterology and Liver Diseases
Albert Einstein College of Medicine
Bronx, NY 10461, USA

A HIV researcher and ethicist by training, Dr. Sean Philpott holds advanced degrees in microbiology, anthropology, and bioethics. He is currently Assistant Professor of Bioethics at Union Graduate College, where he teaches research ethics and coordinates Union Graduate College’s Fogarty-funded Advanced Certificate Program in Research Ethics for Central and Eastern Europe. In addition, he is Chair of the US Environmental Protection Agency’s Human Studies Review Board, which reviews the scientific and ethical aspects of research involving human participants submitted to the EPA for regulatory purposes.
Before joining Union Graduate College he was Science and Ethics Officer for the Global Campaign for Microbicides, an advocacy project at an international non-profit organization called PATH, where his work focused on building the capacity of developing country researchers and stakeholders to design, conduct and monitor clinical trials of new user-controlled tools to prevent HIV and other sexually transmitted infections.

Research Ethics
Clinical Trials
HIV Prevention
HIV Treatment
International Research